ResMed RMD

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
-$1.55 (-0.69%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

ResMed (RMD) Business Model and Operations Summary
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Key Insights

ResMed (RMD) Core Market Data and Business Metrics
  • Latest Closing Price

    $222.3
  • Market Cap

    $32.61 Billion
  • Price-Earnings Ratio

    26.25
  • Total Outstanding Shares

    146.91 Million Shares
  • Total Employees

    10,140
  • Dividend

    $0.53 Per Share Quarterly
  • IPO Date

    June 2, 1995
  • SIC Description

    Surgical & Medical Instruments & Apparatus
  • Primary Exchange

    New York Stock Exchange
  • Headquarters

    9001 Spectrum Center Blvd., San Diego, CA, 92123

Historical Stock Splits

If you bought 1 share of RMD before October 3, 2005, you'd have 4 shares today.
Execution DateSplit Amount
August 31, 20102-for-1
October 3, 20052-for-1

Cash Flow Statement

January 1, 2024 to December 31, 2024
MetricValue
Net Cash Flow From Investing Activities$-114.21 Million
Net Cash Flow From Investing Activities, Continuing$-114.21 Million
Net Cash Flow From Financing Activities$-1.03 Billion
Net Cash Flow, Continuing$334.61 Million
Exchange Gains/Losses$-22.91 Million
Net Cash Flow$311.70 Million

Income Statement

January 1, 2024 to December 31, 2024
MetricValue
Basic Earnings Per Share$8.49
Selling, General, and Administrative Expenses$952.70 Million
Preferred Stock Dividends And Other Adjustments$0
Research and Development$318.83 Million
Income/Loss From Continuing Operations After Tax$1.25 Billion
Cost Of Revenue$2.05 Billion

Comprehensive Income

January 1, 2024 to December 31, 2024
MetricValue
Comprehensive Income/Loss Attributable To Parent$1.16 Billion
Comprehensive Income/Loss$1.16 Billion
Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
Other Comprehensive Income/Loss$-163.28 Million

Balance Sheet

January 1, 2024 to December 31, 2024
MetricValue
Fixed Assets$520.16 Million
Noncurrent Assets$4.31 Billion
Long-term Debt$662.86 Million
Other Current Liabilities$631.65 Million
Assets$7.14 Billion
Accounts Payable$220.31 Million

Historical Dividends

Current dividend: $0.53 Per Share Quarterly
Announcement DatePayment DateRecord DateAmountFrequency
Jan 30, 2025Mar 20, 2025Feb 13, 2025$0.53Quarterly
Oct 24, 2024Dec 12, 2024Nov 7, 2024$0.53Quarterly
Aug 1, 2024Sep 19, 2024Aug 15, 2024$0.53Quarterly
Apr 25, 2024Jun 13, 2024May 9, 2024$0.48Quarterly
Jan 24, 2024Mar 14, 2024Feb 8, 2024$0.48Quarterly
Oct 26, 2023Dec 14, 2023Nov 9, 2023$0.48Quarterly

Recent Headlines From The Web

Latest news, press releases, and media coverage about RMD from trusted financial sources

    Related Companies

    Publicly traded companies similar to ResMed (RMD)